Nile Therapeutics, Inc. (Nasdaq: NLTX) today announced that, on June 1, 2010, the Company received a letter from The Nasdaq ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE